Seventeen American cruise ship passengers and five French nationals were evacuated from the MV Hondius after a hantavirus outbreak [1, 3].
The incident highlights the complexities of managing rare viral outbreaks in international travel environments where rapid repatriation and biocontainment are necessary.
Passengers arrived at Omaha Eppley Airfield in Nebraska around 2:30 a.m. ET on Monday [2, 4]. Following their arrival, the passengers were taken for medical assessment at the University of Nebraska Medical Center in Omaha [2, 4].
Health officials said that one of the 17 American passengers [1, 2] tested positive for the hantavirus [1, 3]. While reports on the patient's condition vary, with some sources stating the passenger is not showing symptoms and others describing the case as mild, officials confirmed the positive result [3, 5]. Another American passenger reportedly exhibited mild symptoms [5].
In addition to the U.S. citizens, five French nationals were repatriated to Paris [1]. One French woman among that group also tested positive for the virus [1, 3].
Public health officials are working to manage the situation without causing widespread alarm. "This is not COVID and we don't want to treat it like COVID. We don't want to cause a public panic over this," the CDC Acting Director said [3].
U.S. health officials said that the American passenger who tested positive was not showing any symptoms at the time of the report [5]. The evacuation and subsequent testing were prompted by the outbreak aboard the MV Hondius to ensure the safety of all travelers, and the public [1, 3].
“"This is not COVID and we don't want to treat it like COVID."”
The use of the University of Nebraska Medical Center—a facility known for its high-level biocontainment units—indicates a cautious approach by U.S. health authorities to isolate the hantavirus. Because hantavirus is rare and typically associated with rodent exposure rather than person-to-person transmission, the CDC's emphasis on avoiding 'public panic' suggests a desire to prevent the mischaracterization of the outbreak as a contagious pandemic event similar to COVID-19.
